Product Information

ESLICARBAZEPINE 400 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.6741 per EA under NDC 31722042930. Its NADAC has been published 65 times since Aug 20, 2025.

FDA first approved this application on Aug 3, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ESLICARBAZEPINE 400 MG TABLET

Eslicarbazepine acetate
$1.6741per EA

Strength

400 mg/1

NDC

31722042930

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ESLICARBAZEPINE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211186

FDA Approved

8/3/2023

TE Code

AB

On Market Since

8/3/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for ESLICARBAZEPINE 400 MG TABLET has been published 65 times since Aug 20, 2025, and over the history we have for it it has declined 64.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6741 per EA
All-time high$4.7606 (Sep 10, 2025)
All-time low$1.6741 (Oct 21, 2026)
52-week high$3.6215
52-week low$1.6741
Median price$3.1680
Average price$3.1431
Largest weekly change-19.1% (Aug 19, 2026)
Weeks tracked65
Tracking sinceAug 20, 2025

Price History

1W

0.0%

1M

-9.5%

3M

-36.2%

6M

-44.6%

1Y

-58.6%

3Y

N/A

5Y

N/A

All

-64.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ESLICARBAZEPINE 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ESLICARBAZEPINE 400 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.6741 per EA (NDC 31722042930), effective Nov 11, 2026.

How has the price of ESLICARBAZEPINE 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for ESLICARBAZEPINE 400 MG TABLET has declined 64.8%. It has been tracked across 65 weekly CMS publications since Aug 20, 2025.

What are the highest and lowest recorded NADAC prices for ESLICARBAZEPINE 400 MG TABLET?

Since Aug 20, 2025, the NADAC for ESLICARBAZEPINE 400 MG TABLET has ranged from a low of $1.6741 (Oct 21, 2026) to a high of $4.7606 (Sep 10, 2025), with a median of $3.1680 per EA.

Are there cheaper alternatives to ESLICARBAZEPINE 400 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ESLICARBAZEPINE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ESLICARBAZEPINE 400 MG TABLET?

ESLICARBAZEPINE 400 MG TABLET (NDC 31722042930) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.